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We hypothesised that rehabilitation specifically addressing balance in Parkinson’s disease patients might improve not only balance
but locomotion as well. Two balance-training protocols (standing on a moving platform and traditional balance exercises) were
assessed by assigning patients to two groups (Platform, n = 15, and Exercises, n = 17). The platform moved periodically in the
anteroposterior, laterolateral, and oblique direction, with and without vision in different trials. Balance exercises were based on
the Otago Exercise Program. Both platform and exercise sessions were administered from easy to difficult. Outcome measures
were (a) balancing behaviour, assessed by both Index of Stability (IS) on platform and Mini-BESTest, and (b) gait, assessed by
both baropodometry and Timed Up and Go (TUG) test. Falls Efficacy Scale-International (FES-I) and Parkinson’s Disease
Questionnaire (PDQ-8) were administered. Both groups exhibited better balance control, as assessed both by IS and by Mini-
BESTest. Gait speed at baropodometry also improved in both groups, while TUG was less sensitive to improvement. Scores of
FES-I and PDQ-8 showed a marginal improvement. A four-week treatment featuring no gait training but focused on
challenging balance tasks produces considerable gait enhancement in mildly to moderately affected patients. Walking problems
in PD depend on postural instability and are successfully relieved by appropriate balance rehabilitation. This trial is registered
with ClinicalTrials.gov NCT03314597.
1. Introduction
Exercise is the foundation of physical rehabilitation in
patients with movement disorders of various nature [1].
Increases in levels of brain-derived neurotrophic factor and
brain plasticity would be accountable for this effect [2, 3].
However, much is to be desired regarding the characteriza-
tion of type and dosage of the exercise to be administered
to patients affected by movement disorders. Treatment
for patients with Parkinson’s disease (PD) is no exception
[4, 5]. In their review, Tomlinson et al. [5] addressed different
physiotherapy techniques but observed that evidence is
insufficient for favouring one intervention over another. In
the case of patients with PD, a further conundrum is repre-
sented by their high risk of falling, by their balance and gait
conditions (and by the unpredictable interactions between
the two functions) [6], by their reduced limits of stability
[7] and biased representation of verticality [8, 9], and by their
abnormal excitability of the long-loop reflexes subserving
postural responses [10, 11]. In addition, they have different
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needs of rehabilitation treatment depending on the stage of
disease and medication [12]. These conditions require
adapted intervention [13, 14].
Treadmill training is a relatively popular type of exercise,
because impaired locomotion is one of the most annoying
signs of the disease. This training is easy to administer, can
be repeated regularly, and can be practiced at home at the
end of the inpatient period with relatively little cost. A recent
Cochrane survey, based on data with an overall moderate
quality of evidence, confirmed a mild improvement by
treadmill training of gait speed and stride length [15]. A
conjecture about the limited success of treadmill training is
that locomotion also requires adequate balance control in
addition to effective rhythmic activation of the hind limb
muscles [16–18]. In this line, it is noteworthy that cycle
ergometer training improves gait as much as treadmill train-
ing inPDpatients [19]. Yet, balance controlmaybe less critical
during treadmill walking (or cycling) than during overground
walking, since the former reduces variability in the gait
parameters [20], requiring less cycle-to-cycle correction.
One might envisage that selective training of locomotion
by treadmill would not be enough for comprehensive reha-
bilitation of walking but that optimal success could be
achieved when balance is also trained [21]. Or, perhaps, even
balance training alone could improve locomotion as much as
treadmill training does [22]. The importance of training bal-
ance in connection with rehabilitation aimed at improving
gait is easily stressed by considering the complex motor
behaviour underpinning more challenging conditions than
linear walking, as walking-and-turning, where the turn-
related changes in feet, trunk, and head movements are inte-
gral part of the kinematics of the steering body [23–28]. It is
no wonder that freezing of gait and increased risk of falling
[29] is associated with abnormal bilateral coordination and
turning. Hence, the present investigation somehow diverges
from the theory of the task-specific training [30] but con-
siders instead the relevance for locomotion enhancement of
training balance control, by hypothesising that specific bal-
ance rehabilitation might be sufficient for gait improvement.
Here, we trained patients with PD with two different
treatments, both specifically addressing balance. A platform
onto which subjects stood moved in the anteroposterior,
laterolateral, and diagonal direction in the horizontal plane.
This platform protocol challenges both the anticipatory and
the reactive capacities to the ongoing postural perturbations,
thereby training dynamic balance control, aiming at the bal-
ance problems encountered during everyday activity. This
protocol was based on a simpler moving-platform protocol
that had been previously exploited for testing and enhancing
balance capacities in patients with PD and with vestibular
deficit [31–33]. The outcome of the platform treatment was
compared to that obtained in another group of matched PD
patients by standardised and validated exercises aimed at
training balance and dynamic balance [34]. Of note, these
exercises contained no dynamic component (i.e., gait-
related exercises) of balance training, contrary to [35]. Both
treatments (platform and exercises) were tailored to the
patient individual capacities, and their difficulty gradually
increased all along the duration of the treatment [35]. We
estimated any improvement in balance control both by
indexes of dynamic stability during a balance perturbation
trial on the mobile platform and by clinical scores assessing
balance control. Gait improvement was evaluated both
instrumentally and by a functional clinical test.
2. Methods
2.1. Participants. Thirty-eight patients with mild to moderate
idiopathic Parkinson’s disease (PD) (Hoehn–Yahr stage
between 1.5 and 3) were recruited from the local association
of Parkinson’s disease patients and from our laboratory data-
base. All patients had a diagnosis of idiopathic PD based on
defined criteria [36], and all were on stable dopaminergic
medication (see Table 1). They did not change their pharma-
cological therapy during the study. No patient had orthopae-
dic conditions restricting exercise or had deep brain
stimulation surgery, or showed evidence of cognitive dys-
function according to the Mini-Mental State Examination
(MMSE) (Table 1). All patients could walk independently.
From the patients initially screened, six were excluded
according to the above criteria. Twenty-one men and eleven
women finally participated in the study. The Internal Advi-
sory Board of the Institute of Veruno approved the protocol
(approval number 905 CEC), and informed consent was
obtained from all the patients.
Patients were randomly assigned to two different groups
of training: balance exercise training (PD-E, n = 17) and
mobile platform training (PD-P, n = 15). The method of
sequence generation relied on a computerized random
number generator. All patients were naive to the experi-
mental procedure, and all succeeded in performing the
tasks. We used the motor section (III) of the UPDRS [37],
composed of 14 items, to assess specific disorders such as
bradykinesia, rigidity and tremor, balance, and functional
mobility [38]. Table 1 provides the patients’ characteristics
for the two groups.
2.2. Rehabilitation Program. Each of the ten sessions was
composed of 45 minutes of balance exercises (PD-E) or
mobile platform (PD-P) training, each treatment being
followed by a 15min final phase of lower limb stretching,
performed with the assistance of a physiotherapist. Sessions
were repeated two or three times a week, with at least one rest
day between one session and the next, over four successive
weeks. Each patient was treated on-phase, at the same time
of the day across sessions.
2.2.1. Balance Exercises (17 Patients). Patients in the PD-E
group received a personalized exercise program developed
by an expert physiotherapist. There was no predefined dura-
tion for each item of the set of exercises, but all patients
underwent an overall 45min period training per day accord-
ing to the same schedule. This schedule (see Table 2) was
based on the Otago Exercise Program [34] and practice
guidelines for the treatment of Parkinson’s disease [39, 40].
Patients did not wear shoes during the balance training.
The exercises were performed without upper-limb support
and with the supervision of a physiotherapist. This took note
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Table 1: Demographics, clinical details, and medication of the 32 patients with PD who participated in the study, divided into the two
training groups: PD-E (exercises) and PD-P (platform). The two groups were homogeneous at baseline, as shown by Student’s t-test and
Mann–Whitney U test.
Group Sex
Age
(years)
Body
weight
(kg)
Height
(cm)
Duration
(years)
MMSE Hoehn–Yahr
UPDRS
motor
score
Medication (mg/die)
LED
(mg)
PD-E
M 70 76 160 12 27.03 3 12 LD (937.5), PR (2.1), RA (1) 1248
M 75 83 178 4 23 2 20 PR (3.15), RA (1) 415
M 63 75 160 4 29 2 10 LD (187.5), RA (1), RT (8) 528
M 71 63 167 6 27 2 17 LD (375), PR (0.52), RA (0.5) 477
W 68 62 168 11 30 2.5 20
EN (800), LD (500), RA (0.5), RO
(8), RT (4)
995
M 81 75 167 8 26.4 2 12 LD (625), PR (0.52) 677
W 58 53 167 11 30 2 21 EN (800), LD (656.25), PR (1.05) 978
M 66 69 166 3 27.9 2.5 11 LD (437.5), RO (24) 918
M 66 65 172 6 27.9 2.5 21 LD (125), RA (1), RO (8) 385
M 71 65 165 12 25.4 2.5 18
EN (400), LD (250), PR (2.1), RA
(1)
643
W 51 90 173 10 30 2 19 LD (312.5), PR (2.1), RA (1) 623
M 70 76 180 9 30 2.5 22
AM (50), EN (600), LD (375), PR
(0.52), RA (0.5)
651
M 54 68 167 7 30 2.5 31 RA (1), RO (16) 420
W 72 63 160 1 30 1.5 9 PR (0.52) 52
M 69 72 170 5 26.9 2 17 LD (125), RA (1), RO (10) 425
M 80 55 170 8 28.7 2.5 13 LD (500), PR (1.57), RA (2) 857
M 71 82 168 1 25.3 3 24 PR (1.05), RA (1) 205
Mean 68.0 70.1 168.1 6.9 27.9 2.3 17.5 617.5
SD 8.0 9.9 5.6 3.6 2.1 0.4 5.8 307.4
PD-P
M 66 85 179 13 26.9 2.5 14 LD (125), PR (2.1), RA (1), RT (8) 675
W 67 75 152 10 23 2.5 13
AM (200), LD (1000), PR (0.26),
RA (1), RT (8)
1566
M 79 62 170 12 23 2 20
M (150), EN (800), LD (637.5),
PR (2.1), RA (0.5)
1258
W 66 49 170 6 27 2.5 19 PR (3.41), RA (1) 441
M 80 69 160 8 28.7 2.5 10 LD (893.75), RA (1) 994
M 67 81 169 3 30 2 14 LD (500), PR (1.57) 657
M 64 94 190 3 30 2.5 22 LD (875), PR (0.52) 927
M 73 92 172 12 28.3 2.5 27
EN (800), LD (706.25), RA (1),
RT (4)
1159
W 62 60 157 5 30 1.5 9 PR (0.52), RA (1) 152
W 70 60 160 10 30 2 23
EN (200), LD (137.5), PR (1.05),
RT (8)
528
M 75 80 170 10 27.4 2.5 24 EN (600), LD (375), RO (16) 819
W 66 65 168 2 27.9 2.5 41 RA (1), RO (14) 380
W 71 50 147 1 27.7 2.5 17 RA (1), RT (6) 280
W 64 75 160 5 30 2.5 24 LD (125), PR (3.15), RA (1) 540
M 72 99 180 4 27.4 2 24 EN (600), LD (281.25), RT (6) 554
Mean 69.5 73.1 166.9 6.9 27.8 2.3 20.1 728.7
SD 5.5 15.6 11.2 4.0 2.3 0.3 8.0 390.7
Student’s t-test 0.56 0.58 0.69 0.92 0.38
Mann–Whitney’s
U test
0.89 0.33 0.28
SD: standard deviation; M: man; W: woman; MMSE: Mini-Mental State Examination; UPDRS: Unified Parkinson’s Disease Rating Scale; AM: amantadine;
EN: entacapone; LD: levodopa; PR: pramipexole; RO: ropinirole; RA: rasagiline; RT: rotigotine; LED: levodopa equivalent dose [98].
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of the exercises performed and adjusted the progressive
increase in the exercises’ difficulty. In each session, each
patient performed exercises in an order from easy to difficult,
as depicted in Figure 1(a), based on subject-ability and item-
difficulty maps of the Mini-BESTest, according to [41].
2.2.2. Mobile Platform (15 Patients). Patients (PD-P) entered
the mobile platform and put on a security harness (no weight
unloading), which they wore during the entire training ses-
sion. Their arms were free to move, but they were asked not
to reach out for support. Each patient underwent 45 minutes
of training (resting periods included), in which from 6 to 8
perturbation patterns were administered, each one lasting
about 4 minutes. In order to improve balance control in
different directions, in separate trials, subjects stood on the
platform with different whole-body orientation with respect
to the platform direction of motion. During training, the
platform moved in the anteroposterior, laterolateral, and
diagonal (45 deg) direction with respect to the body. The
periodic platform displacement was 10 cm, regardless of the
frequency, which could range from 0.3 to 0.6Hz. Patients
stood with eyes open and closed and feet together or 20 cm
apart depending on the perturbation subtype. There was no
predefined duration for each subtype of platform perturba-
tion, but all patients were treated according to the same pro-
gressive schedule, from easy to difficult, based on the capacity
of the patient to withstand the platform perturbation config-
uration. The actual mean distribution and duration of the
sessions is depicted in Figure 1(b).
2.2.3. Stretching (All Patients). All patients of both groups
underwent a stretching exercise program as well, as recom-
mended by several guidelines [39, 40]. The stretching
program included three bouts of lower-limb muscle stretch-
ing: quadriceps, hamstring, and calf, bilaterally. Stretching
was administered with the aid of the physiotherapist. It lasted
about 15 minutes and was performed at the end of each ses-
sion of balancing exercises or platform training.
2.3. Assessment Procedure. At baseline assessment, we
recorded the patients’ clinical characteristics (gender, age,
disease duration, body weight, and height) and disability
(Mini-Mental State Examination, Hoehn–Yahr staging of
Parkinson’s Disease, and the motor section of the Unified
Parkinson’s Disease Rating Scale) (see Table 1). Data collec-
tion both at baseline (T1) and at the end of training (T2, the
day following the last training session) contained physical
tests of balance and gait performance and scores of self-
reported questionnaires about fear of falling and impact of
PD on quality of life (as detailed below). All evaluations
were collected by a physical therapist blinded regarding
the allocation of the patients. All participants were assessed
during the on-phase and at the same time of the day at T1
and T2.
2.3.1. Balance Outcome Measures. These were balance behav-
iour indexes, assessed by (1) the dynamic balance test on the
mobile platform and (2) the Mini-BESTest.
(1) Assessment of Balancing Behaviour by Sinusoidal Transla-
tion of the Supporting Platform. This dynamic-balance test is
a sensitive tool for detecting instability in PD [42, 43]. The
subjects stood upright on the platform that moved continu-
ously 10 cm forward and backward on the horizontal plane
at a frequency of sinusoidal translation of 0.4Hz. The entire
test comprised 60 cycles of motion, lasting 2 and a half
Table 2: Balance exercises administered to the PD-E group, based on the Otago Exercise Program [33] and guideline program for Parkinson’s
disease [38, 39].
Exercise Description & dose Progression
Tandem
Place a foot straight in front of the other, with the heel
touching the toe.
Keep your balance 30 s long, then reverse your feet.
Repeat this exercise 3 times for each foot.
Difficulty was raised according to patient’s skills. Starting
with half-tandem (feet not near together), going on with
tandem performed on different surfaces like foam and
inclined ramp.
Difficulty was further increased by keeping the eyes closed.
One leg stance
Look straight ahead. Keep your hands on your hips. Lift on
your leg without touching or resting your raised leg upon
other standing leg. Stay standing on one leg 30 s long, then
switch between one foot and the other.
Repeat this exercise 3 times for each foot.
Difficulty was raised according to patient’s skills by utilizing
different surfaces like foam or keeping one foot lifted up a
step.
Difficulty was further increased by keeping the eyes closed.
Inclined ramp
Stand upon the inclined ramp with toes toward the top.
Place feet shoulder-width apart. Maintain the position 45 s
long, then turn around in order to have the top by your side.
Repeat for each side and one more time with the top behind.
Difficulty was raised according to patient’s skills by closing
up feet. Difficulty was further increased by keeping the eyes
closed.
Stance
Place your feet together until almost touching, looking
straight ahead. Be as stable and still as possible.
Keep the position 60 s long and repeat 3 times each exercise.
Difficulty was raised according to patient’s skills by
performing exercises on foam surfaces, by closing up the feet
or by keeping the eyes closed.
Compensatory
stepping
correction
Stand in front of the physiotherapist and lean on his hands.
When support is released, make a step to maintain balance.
In the same way, the physiotherapist can elicit backward
stepping response and lateral stepping response.
Difficulty was increased by keeping the eyes closed.
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min. All subjects were blindfolded, their sagittal axis coplanar
with the direction of platform movement. Subjects wore a
security harness and listened to music through noise-
reducing earphones to mask the faint sound produced by
the platform mechanism. A physiotherapist stood by the side
to support the patient in case of balance loss. Body move-
ments were recorded by detection of 3 reflective markers
placed on the tragus (head), greater trochanter (hip), and lat-
eral malleolus (invariable with respect to the moving plat-
form). The instantaneous markers’ position was recorded by
means of a stereometric device (four cameras, Vicon 460,
Oxford Metrics, UK) at a sampling frequency of 120Hz. Dis-
placements of markers were automatically interpolated and
reproduced off-line by the motion analysis software.
We noted the number of cycles completed by each
patient, both at baseline evaluation (T1) and at the end of
the 10 training sessions (T2). Also, as an index of the average
extent of back and forth displacement of the body segments
in the sagittal plane (Index of Stability, IS), the standard devi-
ation (SD) of head and hip markers’ traces along the antero-
posterior axis over time was computed [33, 44]. The latter is
influenced both by the periodic peak-to-peak body displace-
ments directly linked to the platform movement and by any
other body displacement, not openly connected with the
platform oscillation pattern. For comparison, the IS of the
trace of the malleolus marker gave the reference value for
the platform movement. Since not all patients performed
the entire number of cycles at baseline, the calculation of
the mean value of the IS was made on the cycles actually exe-
cuted by patients.
(2) Assessment of Balance by Clinical Evaluation. The
Mini-Balance Evaluation Systems Test (Mini-BESTest) is a
14-item balance scale that takes 15min to administer. It spe-
cifically addresses dynamic equilibrium and is highly reliable
[41]. Each item is scored on a 3-level ordinal scale from 0 to
2, with 2 representing no impairment and 0 representing
severe impairment of balance. The total score ranges from 0
to 28. The Mini-BESTest has shown a high interrater and
test-retest reliability for people with balance disorders [45]
and patients with PD [46].
2.3.2. Gait Outcome Measures. These were collected by (1)
baropodometry and (2) the TUG test.
(1) Assessment of Gait Performance by Baropodometry. An
electronic walkway (GAITRite®, CIR Systems, Sparta, NJ,
USA) returned the baropodometric gait variables. The walk-
way is 460 cm long, has an area of pressure sensors of
366 cm× 61 cm containing 13,824 active sensors, and has a
sampling frequency of 80Hz. The GAITRite system has
validity and test-retest reliability in patients with PD [47].
Patients were instructed to walk at their usual velocity. They
began walking 2m before the walkway and continued for 2m
past the end, in order to eliminate acceleration and decelera-
tion events from the acquisition. After one familiarizing trial,
the data from four successive trials were recorded. Gait speed,
step length, and cadence were averaged over the four trials.
(2) Assessment of Timed Up and Go Test (TUG). To evaluate
gait in a functional situation of daily living, we used the TUG
test. This is a functional measure in which subjects stand up
from a chair, walk past a horizontal line marked with tape on
the floor at 3m from the start, turn around, walk back, and sit
down at their comfortable pace [48]. TUG duration greater
than 16 s indicates an increased risk of falls in patients with
PD [49]. The test has demonstrated an excellent test-retest
and interrater reliability in PD [50]. Three trials were per-
formed, timed with a stopwatch, and the results obtained
from the last two trials were averaged.
2.3.3. Secondary Outcome Measures
(1) Fear of Falling. In order to evaluate fear of falling, all
patients filled the Falls Efficacy Scale-International (FES-I).
It is a self-report questionnaire developed for use in elderly
populations to assess fear of falling [51]. A series of 16 ques-
tions assesses the respondent’s fear of falling for a range of
Tandem
Standing
Tilt table Compensatory step
OLS
11%
35%
16%
16%
22%
(a)
0.3 Hz
0.4 Hz
0.5 Hz
0.6 Hz
17%
22%
28%
33%
(b)
Figure 1: (a) Distribution of the exercise subtypes in % of the total duration of the balance training sessions. The data originate from of all
patients and all sessions collapsed. OLS: one leg stance. (b) Distribution of the platform perturbation subtypes in % of the total duration of the
platform training sessions, all patients, and all sessions collapsed. Each patient was trained with from easy to difficult conditions.
5Neural Plasticity
ADLs. Each question was rated on a four-point scale from 1
(“not at all concerned” about falls) to 4 (“very concerned”).
(2) Impact of PD on Quality of Life. The Parkinson’s
Disease Questionnaire (PDQ-8) is an 8-item self-report
questionnaire derived from its parent questionnaire, the
PDQ-39 [52]. It exhibits appropriate levels of reliability,
validity, and responsiveness [53]. Each item was rated using
a five-point scale, corresponding to the frequency with
which symptoms occur (from “never” to “always”). Total
score ranges from 0 to 32. A higher total score reflects a
lower health-related quality of life. All patients filled both
subjective questionnaires with the aid of a physiotherapist
blinded regarding the allocation of the patients. No problems
were encountered in correctly understanding and answering
the questions.
2.4. Statistical Analysis. Seventeen patients were allocated in
the PD-E (exercise) group and fifteen patients in the PD-P
(platform) group. Sample size was chosen based on data from
two previous studies performed in our laboratory employing
the continuous platform perturbation as a means of training
balance [31, 33]. The prospective power calculation had
shown that a sample size of 15 would have 80% power to
detect a mean difference in the Index of Stability of head dis-
placement of 10mm using a one-sided paired Student’s t-test
with alpha= 0.05.
For all recorded variables, a test for normality (Shapiro–
Wilk) was performed prior to statistical comparison of the
differences. To detect differences between the clinical charac-
teristics of the two groups at T1, nonpaired Student’s t-tests
were performed for age, disease duration, body weight, and
height. The Indexes of Stability (IS) of the head, hip, and mal-
leolus in the mobile-platform assessment, the TUG duration,
and the gait characteristics (speed, cadence, and step length)
were normally distributed. These variables were compared
between the groups at T1 by the nonpaired Student’s t-test.
The Mann–Whitney U test was used for MMSE, Hoehn–
Yahr, and UPDRS scores.
The pre- to postrehabilitation differences of the normally
distributed variables were assessed by repeated-measure
ANOVA, with the groups (PD-E and PD-P) as independent
factors. When ANOVA gave a significant result (p < 0 05),
the post hoc Tukey’s test was used to assess significant differ-
ences between the variables evaluated for each group.
The distribution of the number of cycles in the dynamic
test proved to be nonnormal by Shapiro–Wilk test. For this
reason, we used the Wilcoxon signed rank test to compare
total number of cycles between pre- and post-balance treat-
ments within each group. The same was done for the total
scores of the ordinal variables (Mini-BESTest, FES-I, and
PDQ-8). To assess the difference in these variables between
the two patient groups at baseline and after rehabilitation,
the Mann–Whitney U test was run.
Regression analysis was used for estimating relation-
ships among variables, with a focus on the relationship
between the value of a variable of interest posttreatment
and pretreatment (considered as predictor). This analysis
was made for speed and TUG duration. It was also applied
to assess the degree of improvement as a function of the
medication dosage.
For Mini-BESTest and gait speed, the response rate was
the percentage of patients that improved after treatment, esti-
mated by using the minimal detectable change (MDC). Cut-
off for determining improvement was based on the values
reported in [45] for the Mini-BESTest and [15] for gait. Dif-
ferences in response rate between the groups (PD-E versus
PD-P) were analyzed using Fisher’s exact test (2-tailed).
Results are reported in the text and figures as mean± SD.
Statistical analysis was performed using Statistica (StatSoft
Inc., Tulsa, OK, USA).
3. Results
3.1. Participant Selection. Figure 2 is a CONSORT flow dia-
gram [54] showing the trial profile. No dropouts were
recorded during the treatment, and all subjects completed
the rehabilitative protocols.
3.2. Characteristics of the Patients. Table 1 shows the clinical
characteristics of the patients. Thirteen men and four women
underwent the balance exercise training (PD-E), while eight
men and seven women underwent the mobile platform train-
ing (PD-P). The difference in the number of men and women
between the two groups was not significant (p = 0 17, chi-
squared test). There were no differences between the groups
in age (p = 0 56), disease duration (p = 0 92), MMSE (p =
0 89), Hoehn–Yahr stage (p = 0 33), and UPDRSmotor score
(p = 0 28).
3.3. Effects of the Rehabilitation Treatments (PD-P and PD-
E Groups)
3.3.1. Improved Balancing Behaviour as Assessed by the
Sinusoidal Translation of the Supporting Platform and by
the Mini-BESTest
(1) Moving Platform. Figure 3(a) shows the effects of both
treatments on the dynamic balance test with the mobile plat-
form. At the baseline evaluation (T1), only 10 patients in
each group were able to complete the test (up to 60 cycles).
No difference was present in the mean number of cycles
between the two groups at T1 (p = 0 59). After training
(T2), more patients completed the test (13/17 PD-E and
14/15 PD-P) and each patient endured more perturbation
cycles. No difference was present in the mean number of
cycles between the two groups at T2 (p = 0 47). In spite of
enduring longer perturbation periods, no significant differ-
ence was found in the mean number of cycles between T2
and T1 within each group, likely because of the large vari-
ability across patients (p = 0 35 and p = 0 28, for PD-E and
PD-P, resp.).
Figures 3(b) and 3(c) show the mean Indexes of Stability
(IS) of the head and hip at T1 and the changes at T2 in the
two training groups. A decrease in the IS denotes better
segment stabilization in space. Two-way ANOVA on the IS
of the head showed a difference between the groups
(F(1,30) = 7.60, p < 0 05). There was an overall positive effect
of training (F(1,30) = 33.24, p < 0 0005). The interaction
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between group and treatment did not reach significance
(F(1,30) = 2.53, p = 0 10). The post hoc test showed no signif-
icantdifferencebetween the twogroupsatT1(p = 0 35).At T2,
the IS of the PD-P was smaller than that of the PD-E group
(p < 0 05) (Figure 3(b)). As to the mean IS of the hip marker,
two-way ANOVA showed again a difference between the
groups (F(1,30) = 4.21, p < 0 05) and a significant effect of
training (F(1,30) = 55.75, p < 0 0005). The interaction was
significant (F(1,30) = 9.55, p < 0 005). Post hoc analysis
showed no difference at T1 (p = 0 94). At T2, the IS of hip
marker improved more in the PD-P than in the PD-E
group (p < 0 05) (Figure 3(c)). As a control, we recorded
also the IS for the malleolus marker (Figure 3(d)). Two-
way ANOVA showed no difference between the groups
(F(1,30) = 2.18, p = 0 15). There was a small effect of train-
ing (F(1,30) = 3.79, p < 0 05), connected to the reduction at
T2 of the small displacements of the feet during the perturba-
tion cycles, which was instead present at T1. The training-
group interaction was not significant (F(1,30) = 0.002,
p = 0 97).
(2) Mini-BESTest. Figure 4 shows the average score for
the Mini-BESTest at T1 and T2 in the two patient groups.
At baseline, both groups showed no difference in the scores
(Mann–Whitney U test, p = 0 91). After training, scores
increased significantly in both groups (Wilcoxon test,
p < 0 01). No significant difference (Mann–Whitney U test,
p = 0 18) was found between the groups after training.
Allocated to exercise group
(PD-E), on medication (n = 17)
Received allocated intervention (n = 17)
Allocated to mobile platform group
(PD-P), on medication (n = 15)
Received allocated intervention (n = 15)
Evaluations at baseline, T1 (n = 17)
MMSE, UPDRS III, mobile platform,
baropodometry, Mini-BESTest, TUG,
FES-I, PDQ-8
Exercises training
10 sessions, 60 min/day
3 sessions/week, 4 weeks
Evaluations after 4 weeks, T2 (n = 17)
Mobile platform, Baropodometry, Mini-
BESTest, TUG, FES-I, PDQ-8
Analysed (n = 17)
Excluded from analysis (n = 0)
Assessed for eligibility (n = 38)
Excluded (n = 6)
Not meeting inclusion criteria (n = 6) 
Randomized (n = 32) 
Evaluations at baseline, T1 (n = 15)
MMSE, UPDRS III, mobile platform,
baropodometry, Mini-BESTest, TUG,
FES-I, PDQ-8
Exercise straining
10 sessions, 60 min/day
3 sessions/week, 4 weeks
Evaluations after 4 weeks, T2 (n = 15)
Mobile platform, Baropodometry, Mini-
BESTest, TUG, FES-I, PDQ-8
Analysed (n = 15)
Excluded from analysis (n = 0)
Enrolment
Allocation
Follow-Up
Analysis
Figure 2: Flowchart for participant inclusion, allocation, evaluations, intervention, and analysis. Abbreviations: MMSE: Mini-Mental State
Examination; UPDRS III: Unified Parkinson’s Disease Rating Scale; TUG: Timed Up and Go Test; FES-I: Falls Efficacy Scale-International;
PDQ-8: Parkinson’s Disease Questionnaire, 8 items.
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3.3.2. Improved Locomotion as Assessed by Baropodometry
and by the Timed Up and Go Test
(1) Baropodometry. At baseline, the spatiotemporal vari-
ables of gait (speed, cadence, and step length) were not
different for PD-E and PD-P. After training, gait variables
improved significantly. Two-way ANOVA showed that
there was an effect of training on gait speed (Figure 5(a))
(F(1,30) = 19.50, p < 0 001). No difference was found between
the groups (F(1,30) = 0.17, p = 0 68). There was no interaction
(F(1,30) = 0.29, p = 0 60). Post hoc analysis showed that gait
speed at T1 (p = 0 96) and at T2 (p = 0 94) was similar in
both groups.
As togait cadence (Figure 5(b)), two-wayANOVAshowed
a significant pre- to posttraining difference (F(1,30) = 13.18,
p < 0 005). Cadence slightly increased from 121.0± 7.5
steps/min to 125.6± 8.6 steps/min and from 120.5± 12.9
steps/min to 124.3± 10.6 steps/min, for PD-E and PD-P,
respectively. No difference was found between the groups
(F(1,30) = 0.07, p = 0 80). The interaction between groups
and treatment was not significant (F(1,30) = 0.15, p = 0 70).
Post hoc analysis showed no difference in cadence between
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Figure 3: Training effects on body stabilization assessed by the moving-platform test in the two groups of patients (PD-E and PD-P) at
baseline (T1, yellow columns) and after treatment (T2, pink columns). All subjects were tested at 0.4Hz perturbation frequency, eyes
closed. At T2, patients endured longer periods on the platform than at T1 (a). Head (b) and hip (c) displacement (Index of Stability (IS))
improved significantly after both platform and exercise training, indicating a decrease in body segment oscillation. IS at T2 was better in
the PD-P than in the PE-E group for both the head and hip. (d) shows that feet position on the platform was substantially unvarying for
patients in both groups. Asterisks (∗p < 0 05; ∗∗∗p < 0 0005) indicate differences (T1, T2) within groups and between groups at T2.
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Figure 4: Training effect on balance, measured by the total score
of the Mini-BESTest. Yellow columns represent pretraining and
pink columns posttraining evaluation. A significant difference was
found between T1 and T2 within each group (Wilcoxon test;
∗p < 0 05).
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the groups, either at T1 or at T2 (p = 0 99 and p = 0 98, resp.),
and a small significant increment in cadence for PD-E (p <
0 05) but not for PD-P (p = 0 14).
Therewasamodest but significant effectof trainingonstep
length (ANOVA, F(1,30) = 17.16, p < 0 0005) (Figure 5(c)).
No difference was found between the groups (F(1,30) =
0.20, p = 0 66), and the interaction was not significant
(F(1,30) = 0.36, p = 0 55). Post hoc analysis showed no differ-
ence in step length between the groups, either at T1 or at T2
(post hoc test, p = 0 99 and p = 0 94, resp.), a significant
increment in step length at T2 for PD-E (p < 0 01), and a
marginal increment for PD-P (p = 0 06). At the end of the
training, the mean values of step length slightly exceeded
the lower limit of normality in both groups.
Figure 6 shows the distribution of the individual data
points pertaining to gait speed. Speed values at T2 are plotted
against speed values at T1, for each patient of both groups.
In spite of a considerable scatter of data points in both pop-
ulations, the regressions were significant (y = 0 92x + 20 42,
R2 = 0 75, and p < 0 0001 and y = 0 68x + 44 98, R2 = 0 54,
and p < 0 001, for PD-E and PD-P, resp.). Speed increment
was shown by most patients, except three in the PD-P group
(below the identity line), for whom the gait speed was pretty
high already at T1. The slope of the two regression lines was
not significantly different from the identity line for either
group (p = 0 56 and p = 0 11, for PD-E and PD-P, resp.),
suggesting that the patients with lower gait speed at T1 did
not exhibit a more effective improvement after either train-
ing protocol.
We have checked this by an ANOVA, separately run
for the two treatments. For each treatment, the gait speeds
at T1 were sorted into slow and fast subgroups. Accord-
ingly, ANOVA showed a significant difference in speed
between subgroups (PD-E, F(1,15) = 28.37, p < 0 0001; PD-
P, F(1,13) = 25.84, p < 0 0001). There was a significant effect
of treatment on velocity at T2 (PD-E, F(1,15) = 22.25,
p < 0 0001; PD-P, F(1,13) = 5.29, p = 0 038), but there was
no interaction between subgroup and velocity (PD-E,
F(1,15) = 0.02, p = 0 88; PD-P, F(1,13) = 1.73, p = 0 22),
indicating no extra advantage for the patients with a slow
gait speed at T1, for either the exercise or the mobile
platform treatment.
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Figure 5: Analysis of the training effects assessed by the baropodometric and clinical measures collected in the two groups at baseline (T1,
yellow columns) and after the treatment (T2, pink columns). Gait speed (a) significantly improved in both groups, while cadence (b) and
step length (c) increased only slightly (significantly so in PD-E). Dashed lines indicate the limits of normality. Time to perform the TUG
test (d) slightly diminished in both groups; cut-off score for fall risk is indicated by the dashed line. Asterisks (∗p < 0 05; ∗∗p < 0 005,
Tukey’s post hoc test) indicate differences within group. No difference was found between groups after training for any variable.
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(2) Timed Up and Go Test. Figure 5(d) shows the average
changes of TUG duration for PD-E and PD-P patients at
T1 and T2. The dashed line indicates the cut-off score for fall
risk in TUG [54]. Two-way ANOVA showed that, both
groups collapsed, training significantly decreased the mean
TUG duration (F(1,30) = 6.68, p < 0 05). No difference was
found between the groups (F(1,30) = 0.64, p = 0 43), and the
interaction was not significant (F(1,30) = 0.37, p = 0 55). Post
hoc analysis showed that TUG duration was similar in
both groups both at T1 (p = 0 77) and at T2 (p = 0 96).
When the effect of treatment was assessed by the post
hoc test within each group, the increments did not reach
significance, likely because of the limited number of patients
per group (p = 0 48 and p = 0 15, for PD-E and PD-P, resp.).
Figure 7(a) shows that the decrement in TUG duration
was remarkable just for the few subjects, the TUG time of
which was long at T1, corresponding to a high risk of
falling, but that no major effect was noted in the subjects
having scores close to normal at T1. Both regressions were
significant (y = −0 60x + 5 35, R2 = 0 82, and p < 0 001 and
y = −0 50x + 4 29, R2 = 0 83, and p < 0 001, for PD-E and
PD-P, resp.). There was no obvious difference between the
two groups.
(3) Correlation between Gait Velocity and Timed Up and Go
Test. Figure 7(b) shows the correlation between the
improvement in TUG scores and the increase in gait speed
at baropodometry, for both groups. Both treatments pro-
duced a limited and scattered percent change in TUG scores
except in a few patients. Neither regression was significant
(y = −0 40x + 0 02, R2 = 0 04, and p = 0 45 and y = −0 27x
– 6 32, R2 = 0 14, and p < 0 17, for PD-E and PD-P, resp.).
3.4. Response Rate of the Two Protocols for Balance and Gait.
Based on the value of the minimal detectable change (MDC)
for the Mini-BESTest, published in [45] (3.5 points), the
treatments improved the score in 11/17 patients of the PD-
E group and in 5/15 patients of the PD-P group. Differences
between groups did not reach significance (Fisher’s exact
test = 3.14, p = 0 08). A similar picture applies to gait speed,
by using the MDC published in [15] (0.09m/s). Treatments
improved speed in 10/17 patients of the PD-E group and 7/
15 patients in the PD-P group. The difference between the
two rates did not reach significance, either (Fisher’s exact
test = 0.47, p = 0 49).
Figure 8 shows the result of the attempt at evaluating
any interaction between medication and the effects of the
rehabilitation treatments on gait speed, in the assumption
that the amount of medication might affect the outcome
of the treatments.
For each patient, the percent change in gait speed is plot-
ted as a function of the levodopa equivalent dose. Regression
lines were drawn through the data points. For both groups,
the lines were almost superimposed, and their slope was
not significant (y = 0 002x + 8 12, R2 = 0 008, and p = 0 74
and y = 0 005x + 5 48, R2 = 0 0016, and p = 0 66, for PD-E
and PD-P, resp.).
3.5. Scores of Self-Reported Questionnaires about Fear of
Falling and Impact of PD on Quality of Life
3.5.1. Fear of Falling. There was a marginal effect of training
on the total score of FES-I (not shown). At baseline, the aver-
age score of FES-I was 23.5± 7.1 and 26.3± 10.7 (Mann–
Whitney U test, p = 0 63) for PD-E and PD-P, respectively.
After training, the average values decreased to 21.2± 5.4
and 24.3± 11.0, respectively. The reduction was marginally
significant (Wilcoxon test, p > 0 08 for both comparisons).
No significant (Mann–Whitney U test, p = 0 38) difference
in the scores between the groups was found after training.
3.5.2. Impact of PD on Quality of Life.At baseline, the average
score of PDQ-8 was 5.9± 6.1 and 8.9± 7.1 (Mann–Whitney
U test, p = 0 16), forPD-E andPD-P, respectively (not shown).
After training, the average values decreased to 4.4± 4.7 and
6.8± 6.3, respectively. The reduction was marginally signifi-
cant (Wilcoxon test, p = 0 06 for both groups). No significant
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Figure 6: (a) This shows the correlation between gait speed pre- and posttreatment, as assessed by baropodometry. Red and blue circles
represent all single subjects of the PD-E and PD-P groups, respectively. Most data points lay above the identity, indicating increased
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(Mann–Whitney U test, p = 0 14) difference between the
groups was found after training.
4. Discussion
The interplay between balance and gait disorders in Parkin-
son’s disease is a matter of debate. Poor postural control is
common in PD patients, is not always improved by dopami-
nergic drugs [55, 56], and interferes with walking [57]. In
other diseases, walking problems are strongly dependent on
impaired balance control as well, as in peripheral neuropathy
[33], stroke [58], and cerebellar syndromes [59]. In PD, mul-
tiple abnormal neural circuits may be responsible for balance
and gait problems [56]. The pars reticulata of the substantia
nigra seems to play a major role in the control of dynamic
balance, while other basal ganglia nuclei exert a superior con-
trol on gait [60]. Mille et al. [61, 62] addressed the integration
of postural motor actions for both balance stabilization and
locomotion in normal subjects and suggested that feedfor-
ward adaptation of locomotion depends on the current pos-
tural conditions. Humans have the ability to control the
position of the centre of body mass on a restricted base of
support in order to maintain equilibrium in both gait [63]
and upright quiet stance [64] and use the vertical as a refer-
ence for the coordination for both postural responses and
locomotion [8]. So, the processes for the control of posture
and locomotion are likely to be interdependent at many dif-
ferent levels of the central nervous system and share some
common principles of organization [57, 64]. On the one
hand, the links between balance and gait would be compro-
mised in PD, and this is perhaps the reason why Massion
[65] found that balance and gait represent independent
domains of mobility in Parkinson’s disease. On the other
hand, one may note that dopaminergic medications and deep
brain stimulation of the subthalamic nucleus provide similar
improvements in balance and gait tasks [66].
Beyond the time-honoured notion that physical activity
of different nature and intensity improves activities of daily
life in PD [67, 68], it is not known whether dynamic-
balance rehabilitation per se can improve not only balance
control but locomotion as well. This information would have
both theoretical implications (locomotion is degraded in PD
mainly because of poor balance control—once the latter is
improved, walking becomes more manageable) and practical
implications (identifications of balance rehabilitation proto-
cols as the main intervention). Interestingly, a manoeuvre
consisting in alternate rhythmic vibration of trunk paraspinal
muscles during quiet stance was able to produce a cyclic
mediolateral transfer of the centre of pressure [69], mimick-
ing accompanying body progression during walking. When
the same type of vibration was applied during gait, walking
velocity, cadence, and stride length improved [70].
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Here, we studied two populations of patients with PD on
stable medication, matched for age and severity of disease.
They were trained with two protocols specifically aimed at
improving dynamic balance and trunk control. In no case
was specific exercises for gait rehabilitation or treadmill
training included. One group underwent a program based
on classified physical exercises, targeting balance. Another
rode a platform, which moved 10 cm back and forth sinusoi-
dally in different directions, a treatment that challenges
dynamic balance by forcing subjects to maintain equilibrium
and adapt to the continuous postural perturbation [33, 44,
71–73]. Both treatments were tailored to the patients’ toler-
ance and gradually increased in difficulty across subsequent
sessions as a function of progressive improvement in
patients’ compliance [4, 35, 74]. Balance-training exercises
are known to improve postural control in patients with Par-
kinson’s disease [75, 76]. Instrumental rehabilitation (contin-
uous displacement of a platform upon which subjects stood)
has been successfully exploited for improving balance in ves-
tibular [31] and neuropathic patients [33]. Both protocols
instruct stabilizing responses to postural perturbations and
are likely to improve trunk control [77]. They also contain
part of the tasks proposed for the rehabilitation of the sense
of verticality [9], which is certainly related to balance and
equilibrium, and are appropriate for challenging sensorimo-
tor integration mechanisms [78].
Protocols partly differ, though. During the exercises, the
base of support and the feet position are being deliberately
changed by using different materials (solid, foam), inclina-
tions (flat, tilted), features (feet parallel, semi-tandem, tan-
dem, and one leg stance), and intervention (push and
release). During the mobile platform protocol, the feet are
parallel and their position in relation to the platform does
not change. The periodic platform displacement trains adap-
tation to balance perturbation by a mix of ankle and hip strat-
egies of different relative weight and by learning to anticipate
postural adjustments [73].
Both balance-training protocols decreased the periodic
oscillations of the head and hip, as tested by means of contin-
uous and periodic anteroposterior displacement of the
support base. The PD-P group reduced head and hip oscilla-
tions slightly more than the PD-E group. In particular, the
centre of mass (the hip marker) appeared to be better con-
trolled in the patients to whom platform training was admin-
istered (PD-P). Most likely, this is connected with the PD-E
patients being naïve to the platform, while the PD-P patients
were already familiar with it because the treatment was based
on a mobile-platform protocol and were likely less suscepti-
ble to the startling effects of the platform displacement [73,
79]. Yet, both protocols had definite positive effects on the
capacity to counteract the balance perturbation test. When
assessed by the Mini-BESTest, the patients belonging to both
groups showed a significant and similar improvement in
dynamic balance. At T1, both groups had been scored “mod-
erate deficit,” and at T2, both were scored “mild deficit to
normal” [80]. The latter is the same category within which
healthy subjects in the same age range are comprised [81].
Thus, both the exercise and the platform treatments have
had an effect on dynamic balance. These effects, though
modest, occurred in spite of the patients assessed at T1 by
the Mini-BESTest not exhibiting major balance problems.
The improvement in locomotion was hypothesised, but
not necessarily expected. In both groups, walking velocity
increased, suggesting that balance exercises or an instrumen-
tal protocol aimed at improving equilibrium has a positive
effect on walking speed. The baropodometric findings
showed that, at T1, both groups’mean step length was below
the lower limit of normality. At T2, step length increased and
rose above the lower limit of normality in both groups.
Cadence increased to a limited extent, coherent with [15]
and with the described relationship between stride length
and cadence [82]. Hence, normalization of step length was
helpful for increasing walking speed. During the single sup-
port phase, propulsion is achieved by slowly braking the
gravity-induced fall of the body through controlled activation
of the triceps surae muscle: the longer the triceps activation
in the supporting leg, the farther the heel contact of the foot
of the swinging leg, therefore, the higher the velocity at con-
stant cadence [83, 84]. This phase of the gait cycle is therefore
substantially a “postural” task, whereby the triceps surae and
erector spinae muscles dynamically control equilibrium [77,
85, 86]. This outcome is particularly significant in PD
patients, in which step length is short because of impaired
capacity of counteracting gravity, leading to the swing leg to
fall short of the expected distance [87].
The time to perform the TUG test also diminished con-
currently with the increase in step length in both groups.
However, the decrement was modest in both groups. In this
connection, Podsiadlo and Richardson [48] found TUG
scores of 10 s or less in healthy elderly people. In our study,
the PD patients had scores close to 10 at T1. Both groups
had an average Hoehn–Yahr stage of 2.3, and this value iden-
tifies a mild disease [88]. These factors would explain the
unremarkable improvement in the TUG test. Schenkman
et al. [89] performed the TUG in PD patients, categorized
into H&Y staging, and their findings suggest that limitations
in the TUG are not revealed until later in the disease progres-
sion, when fatigue and decreased muscle strength would pre-
dominate [90]. So, likely because of its relative complexity
compared to straight walking, and because of a probable ceil-
ing effect, TUG may be inferior to baropodometry for esti-
mating the effects of treatment on walking speed.
Even though the period of training was relatively short,
there was a slight tendency of reduction of the fear of falling
of patients during the execution of activity of daily living, as
evaluated with the FES-I scale. Again, no differences between
patient groups were found. Similarly, in the PDQ-8 scale that
evaluates the health-related quality of life, there was a slight
tendency to reduction, without the prevalence of one
approach over the other.
All in all, the findings are in keeping with the hypothesis
that treatments aimed at improving the dynamic control of
balance improve locomotion in PD patients. In a different
group of PD patients, Arcolin et al. [19] observed an increase
in gait speed after both treadmill and cycloergometer train-
ing. The effect was slightly larger than that observed here,
but those patients exhibited a smaller walking velocity at T1
than the present cohort. Others reported increments in
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walking velocity with treadmill training [91, 92]. A recent
Cochrane review showed that treadmill training improves
gait speed with respect to no intervention, with an effect size
of about 0.40 [15]. In our cohorts, we estimated an effect size
for gait speed of about 0.55 and 0.40, for balance exercise and
mobile platform groups, respectively. This indicates that both
exercise and mobile platform protocols produced an incre-
ment comparable to that of the treadmill training, which is
considered the standard intervention for gait rehabilitation
[93]. The mobile-platform training increased gait speed very
much like the exercises, in spite of both feet resting on the
platform all the time—a task certainly opposite to rhythmic
alternate leg movements. Conversely, mobile-platform train-
ing would have improved head-trunk-leg coordination,
thereby normalizing the activity of trunk muscles, which is
affected in Parkinson’s disease [94]. From a practical point
of view, as also assessed by the evaluation of the response
rates, both treatments alike proved to be similarly effective.
Naturally, the mobile-platform treatment has the benefit of
being quantifiable, standardised, repeatable, and indepen-
dent from the operator. Hence, a simple device producing a
back-and-forth periodic displacement of the support base,
with the option of modifying the frequency and direction of
oscillation, seems to be appropriate for both balance and gait
rehabilitation in Parkinson’s disease.
Of note, all our patients were on medication, with the
drug dosage spanning in an ample range within and across
groups. On the one hand, it is unclear whether medication
affects the capacity of the patients to improve in response
to rehabilitation. On the other hand, the effect of levodopa
on balance and gait is controversial [95, 96] or limited [97].
Therefore, it was interesting to investigate whether patients
improved more or less after rehabilitation as a function of
the equivalent total dose of levodopa [98]. No obvious inter-
action between instrumental or physical-exercise rehabilita-
tion of balance and medication was found. Yet, based on
our admittedly small sample, and on the lack of an ad hoc
control group trained under medication-off condition, we
would not express any strong statement in favour of an
enabling effect of medication on the rehabilitation-induced
improvement of walking.
All in all, we would therefore argue that dynamic-balance
rehabilitation is sufficient for improving locomotion in PD
patients. We would also put forward the notion that walking
problems in PD depend on, or are very closely related to, bal-
ance impairment. This extends to PD the idea that walking
velocity is affected by postural instability, very much as it
has been suggested for cerebellar and neuropathic diseases
[58, 59, 99] or patients with stroke [100] or COPD [101].
To our knowledge, this is the first study that shows improve-
ment in gait induced by mere balance training in patients
with PD. In other types of neurological disease, such as spinal
injury patients, it was found that balance exercises improved
gait [22, 102]. However, in both studies, subjects were admin-
istered exercises also focused on subcomponents of gait.
4.1. Limitations. The relatively unexceptional improvement
in the spatiotemporal variables of gait, in both groups, may
have been limited by the values of these variables at baseline.
Patients recruited in this study had an average Hoehn–Yahr
stage of just 2.3, featuring spatiotemporal variables of gait
at baseline only slightly off the normal range. The effects on
gait of these exclusive balance trainings are based on a small
sample size and should be confirmed in a larger cohort, also
including more severely affected PD patients. In this line, we
would also note that our balance treatments did not overly
improve the Mini-BESTest scoring, either, most likely
because the patients’ scores at T1 were close to those of nor-
mal subjects of the same age.
We do not know whether longer treatments (e.g., [103])
might have granted greater improvements nor are we in the
position of arguing about the duration of the positive post-
treatment effects, in either group. However, based on previ-
ous observations in vestibular patients treated in a similar
way [31], it would not be improbable to observe a protracted
improvement.
4.2. Conclusions. A four-week balance treatment, not con-
taining any gait-rehabilitation exercises, is sufficient for pro-
ducing considerable improvement in walking velocity in
mildly to moderately affected patients with PD. Although
these conclusions are based on small patient numbers, the
data are in keeping with the hypothesis that balance control
is paramount for locomotion in Parkinsonian patients. One
could be even justified to posit that locomotion is degraded
in PD because of poor balance control and to advocate reha-
bilitation of balance as a priority for enhancing gait.
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